Potential synergistic implications for stromal-targeted radiopharmaceuticals in bone-metastatic pros

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:mailxxf
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Prostate cancer(PCa)is the second most common malignancy in men1 and ifloca-lized or confined to the gland at diagnosis,the choice of treatment includes surgery,radiation or watchful waiting.If and when the disease spreads,androgen blockade is effective b
期刊
Avanaifl, a potent new selective phosphodiesterase type 5 (PDE5) inhibitor, has been developed for the treatment of erectile dysfunction (ED). We carried out a systematic review and meta-analysis to assess the efifcacy and safety of this drug for the trea
The explosion of new therapeutics in metastatic castrate-resistant prostate cancer (mCRPC) is unprecedented,but much more work needs to be done before we are satisfied.Six phase Ⅲ trials with an overall survival impact have now been reported (Table 1).1-6
期刊
Fertilisation in mammals involves many synchronized steps including spermegg adhesion.Prior to sperm-oolemma fusion,spermatozoa need to undergo the acrosome reaction (AR) or exocytosis.The universal belief,for many years,has been that the AR was initiated
期刊
Now advertized in at least one locale as the \'sexy ratio\' with the caption,\'Your hands give away your hotness\' (http://io9.com/#!5794008; accessed 3 May 2011),an online summary of a recent study linking facial attractiveness to the ratio of th
期刊